177Lu-DOTATATE for Recurrent Meningioma

NCT06326190 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

136

Enrollment

NETWORK

Sponsor class

Conditions

Recurrent Meningioma

Interventions

DRUG: Local standard of Care
DRUG: 177Lu-DOTATATE

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC

Collaborators

[object Object]